Follow
Bahareh Laribi
Bahareh Laribi
Verified email at ualberta.ca
Title
Cited by
Cited by
Year
Comparison of transplantation of bone marrow stromal cells (BMSC) and stem cell mobilization by granulocyte colony stimulating factor after traumatic brain injury in rat
M Bakhtiary, M Marzban, M Mehdizadeh, MT Joghataei, S Khoei, ...
Iranian biomedical journal 14 (4), 142, 2010
402010
An unpowered sensor node for real-time water quality assessment (humic acid detection)
R Mirzavand, MM Honari, B Laribi, B Khorshidi, M Sadrzadeh, P Mousavi
Electronics 7 (10), 231, 2018
222018
Circulating mesenchymal stem cells, stromal derived factor (SDF)-1 and IP-10 levels increased in clinically active multiple sclerosis patients but not in clinically stable …
R Emamnejad, M Sahraian, Y Shakiba, Z Salehi, A Masoomi, D Imani, ...
Multiple sclerosis and related disorders 35, 233-238, 2019
152019
Combination of stem cell mobilized by granulocyte-colony stimulating factor and human umbilical cord matrix stem cell: therapy of traumatic brain injury in rats
M Bakhtiary, M Marzban, M Mehdizadeh, MT Joghataei, S Khoei, ...
Iranian Journal of Basic Medical Sciences 14 (4), 327, 2011
112011
Characterization of CD4+ and CD8+ T cell subsets and interferon regulatory factor 4 (IRF4) in MS patients treated with Fingolimod (FTY-720): a follow-up study
B Laribi, MA Sahraian, M Shekarabi, R Emamnejad, M Marzban, ...
Iranian Journal of Allergy, Asthma and Immunology, 346-360, 2018
82018
Intravenous injection of human umbilical cord matrix stem cell (Wharton jelly stem cell) provides functional recovery in a rat model of traumatic brain injury
M Marzban, M Bakhtiary, M Mehdizadeh, MT Joghataei, S Khoei, ...
Cell Journal (Yakhteh) 12 (1), 87-96, 2010
82010
Differential serostatus of Epstein-Barr virus in Iranian MS patients with various clinical patterns
B Laribi, M Shekarabi, AH Zarnani, M Ghaffarpour, M Marzban
Medical journal of the Islamic Republic of Iran 32, 118, 2018
32018
Anti‐CD52 blocks EAE independent of PD‐1 signals and promotes repopulation dominated by double‐negative T cells and newly generated T and B cells
Y Haile, A Adegoke, B Laribi, J Lin, CC Anderson
European Journal of Immunology 50 (9), 1362-1373, 2020
22020
Comparison of Epstein Barr virus antibodies and Tcell cytokines production in patients with multiple sclerosis and healthy individuals
B Laribi, M Shekarabi, AH Zarnani, M Ghaffarpour, M Ghabaee, ...
Medical Journal of The Islamic Republic of Iran (MJIRI) 24 (3), 115-120, 2010
22010
Anti-CD52 treatment of EAE is independent of PD-1 signals and differentially affects the proportion of DN T cells, and newly-generated T and B cells
A Adegoke, Y Haile, B Laribi, P Nation, J Lin, C Anderson
EUROPEAN JOURNAL OF IMMUNOLOGY 49, 780-780, 2019
2019
Stem Cell And Regenerative Medicine: O-36: Combination Therapy Of Traumatic Brain Injury In Rats With A Stem Cell Mobilization By Granulocyte-Colony Stimulating Factor And …
M BAKHTIARI, M MARZBAN, M MAHDIZADEH, MT JOGHATAEI, ...
CELL JOURNAL (YAKHTEH) 12 (11), 34-35, 2011
2011
Evaluation of Serum Levels of Anti-Epstein Barr Virus Antibodies and Production of IFN-γ, IL-4 and IL-12 by Mitogen-activated Peripheral Blood Mononuclear Cells in Patients …
M Shekarabi, B Laribi, AH Zarnani, M Ghaffarpour, M Ghabaee, ...
Razi Journal of Medical Sciences 16, 24-31, 2010
2010
Anti-CD52 treatment of EAE is independent of PD-1 signals and differentially affects the proportion of DN T cells, and newly-generated T and B cells
Characteristics and outcomes of patients with multiple myeloma: Data from a developing country
Z Yousefi Ghalejoogh, S Mirakhor Samani, S Shatizadeh Malekshahi, ...
The system can't perform the operation now. Try again later.
Articles 1–14